Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES | 11,831,461 | 11,831,461 | 0 | 132,157 | 279,814 | 39.56% | +147,657 |
| DYNE THERAPEUTICS INC(DYN) | 6,131,079 | 7,845,364 | +1,714,285 | 81,543 | 222,730 | 31.49% | +141,187 |
| ENGENE HOLDINGS INC COM | 8,677,951 | 8,677,951 | 0 | 80,097 | 147,091 | 20.79% | +66,994 |
| ENGENE HOLDINGS INC *W EXP 10/31/202 | 3,878,148 | 2,878,148 | -1,000,000 | 2,446 | 14,966 | 2.12% | +12,520 |
| ACHILLES THERAPEUTICS PLC | 2,390,050 | 2,390,050 | 0 | 2,127 | 2,988 | 0.42% | +860 |
| REPLIMUNE GROUP INC(REPL) | 4,866,499 | 4,866,449 | -50 | 41,024 | 39,759 | 5.62% | -1,265 |